Due to the Covid-19 virus outbreak, Evonik’s contract
manufacturer had to shut-down its production facilities. Both production and
shipping of the amino acid ThreAMINO® are affected.
Dr Emmanuel Auer, Head of Animal Nutrition Business Line at Evonik, explained,
“Regrettably, we are facing a supply shortage for ThreAMINO®. We have therefore
decided to send a Force Majeure notification to our customers with immediate
effect, in accordance with our contracts. Meanwhile, we try the utmost to
mitigate this situation and re-establish supply to our customers as fast as
possible.”
Evonik is keeping its customers regularly informed as the situation develops.
For more information visit the Evonik website, HERE.
The Aquaculturists
No comments:
Post a Comment